Company / Cash per Share
Wave Life Sciences Ltd. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.93
FY2025
5-year range
$1.48 / $3.93
FY2021-FY2025
Trend
+55.2%
vs FY2024
Sector context
#52 of 205
Health Care
What the data says
Wave Life Sciences Ltd.'s cash per share of $3.93 is higher than 75% of companies in the Health Care sector (FY2025). Cash per Share has increased for 3 consecutive years, from $1.48 in FY2022 to $3.93 in FY2025.
Based on SEC 10-K filings.
3.93 in FY2025 with a 5-year CAGR of -6.0%. Top quartile in the Health Care sector.
Improved from $2.30 to $3.93 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +38.6%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 205This company $3.93 Sector average $72.93
▼
-94.6% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 55.2% year-over-year.
- Ranks #52 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.93 | +55.2% |
| FY2024 | $2.54 | +10.0% |
| FY2023 | $2.30 | +55.9% |
| FY2022 | $1.48 | -52.1% |
| FY2021 | $3.09 | -42.5% |
| FY2020 | $5.37 | +7.6% |
| FY2019 | $4.99 | -20.5% |
| FY2018 | $6.28 | +3.6% |
| FY2017 | $6.06 | -13.1% |
| FY2016 | $6.97 | +6672.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026